









Markets
/
Stocks
/
nasdaq-aray
/

Accuray Inc

ARAY

1.220USD

-0.230-15.86%

Close 11/06, 16:00（ET）Quotes delayed by 15 min

138.20MMarket Cap

LossP/E TTM



Accuray Inc

1.220

-0.230-15.86%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Accuray Inc

Currency: USD Updated: 2025-11-06

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Strong Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Accuray Inc's Score

Industry at a Glance

Industry Ranking

72 / 210

Overall Ranking

174 / 4615

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 2 analysts

Strong Buy

Current Rating

4.250

Target Price

+193.10%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Accuray Inc Highlights

StrengthsRisks

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

Overvalued

The company’s latest PE is -7.71, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 81.62M shares, increasing 13.24% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 8.32K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-06

The company's current financial score is 6.95, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 93.94M, representing a year-over-year decrease of 7.49%, while its net profit experienced a year-over-year decrease of 448.25%.

Score

Industry at a Glance

Previous score

6.95

Change



Financials

5.44

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

2.69

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

9.13

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.49

Key Metrics

Free cash flow

No Data

Accuray Inc's Company Valuation

Currency: USD Updated: 2025-11-06

The company’s current valuation score is 6.01, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -7.71, which is -2855.21% below the recent high of 212.37 and -1450.47% above the recent low of -119.51.

Score

Industry at a Glance

Previous score

6.01

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 72/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-06

The company’s current earnings forecast score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Accuray Inc is 4.25, with a high of 4.50 and a low of 4.00.

Score

Industry at a Glance

Previous score

10.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 2 analysts

Strong Buy

Current Rating

4.250

Target Price

+193.10%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Accuray Inc

ARAY

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-06

The company’s current price momentum score is 6.77, which is higher than the Healthcare Equipment & Supplies industry's average of 6.74. Sideways: Currently, the stock price is trading between the resistance level at 1.85 and the support level at 0.85, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.72

Change

0.05

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.066

Sell

RSI(14)

29.590

Sell

STOCH(KDJ)(9,3,3)

21.831

Neutral

ATR(14)

0.103

Low Volatility

CCI(14)

-175.356

Sell

Williams %R

82.679

Oversold

TRIX(12,20)

-0.749

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.372

Sell

MA10

1.428

Sell

MA20

1.563

Sell

MA50

1.602

Sell

MA100

1.494

Sell

MA200

1.633

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-06

The company’s current institutional recognition score is 7.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.40. The latest institutional shareholding proportion is 72.41%, representing a quarter-over-quarter increase of 9.61%. The largest institutional shareholder is The Vanguard, holding a total of 5.48M shares, representing 4.86% of shares outstanding, with 7.58% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

TCW Asset Management Company LLC

11.91M

BlackRock Institutional Trust Company, N.A.

7.22M

+0.25%

The Vanguard Group, Inc.

Star Investors

5.37M

+1.48%

Aevum Fondation de Prévoyance

5.47M

+1.36%

Neuberger Berman, LLC

5.24M

-0.17%

Heartland Advisors, Inc.

5.06M

+18.34%

Armistice Capital LLC

3.24M

+27.60%

Renaissance Technologies LLC

Star Investors

2.60M

-4.37%

Geode Capital Management, L.L.C.

2.42M

+7.77%

Acuitas Investments LLC

1.43M

+0.41%

Risk Assessment

Currency: USD Updated: 2025-11-06

The company’s current risk assessment score is 3.66, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.04. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.